ASTRAZENECA - INDUSTRY SUPPORTED SYMPOSIUM

Print
 

INDUSTRY SPONSORED SYMPOSIUM
Supported by AstraZeneca
THURSDAY, MARCH 16, 2017
17:30-19:00


Are SGLT2 Inhibitors the key to the future?

Welcome: Itamar Raz, Israel

Benefits of SGLT2i in type 2 diabetes beyond glucose control: Graciela Fuente, Argenitina

Too big to fail: the critical intersection of Type 2 diabetes, heart failure and CKD: Mikhail Kosiborod, USA

Discussion, Q&A's: Itamar Raz, Israel